Your browser doesn't support javascript.
loading
The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia.
Halahleh, Khalid; Al Rimawi, Dalia; Abu Ghosh, Amal; Muradi, Isra; Da'na, Waleed; Hamadani, Mehdi.
Afiliação
  • Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Al Rimawi D; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan.
  • Abu Ghosh A; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan.
  • Muradi I; Department of Internal Medicine, University of Tripoli, Tripoli, Libya.
  • Da'na W; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Hamadani M; Internal Medicine, Division of Hematology & Oncology, Medical College of Wisconsin, Wauwatosa, WI, USA.
Hematol Oncol Stem Cell Ther ; 15(4): 219-222, 2022 12 23.
Article em En | MEDLINE | ID: mdl-34352199

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2022 Tipo de documento: Article